Loading
MP
Momenta Pharmaceuticals Inc Stock: price and insider trades · United States
Momenta Pharmaceuticals Inc: what insiders have been doing
Insider filings for Momenta Pharmaceuticals Inc are scarce in the SEC (Form 4) feed, the latest one published on 11 February 2016. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
1 ops. · all time
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
RevenueUS$20.7M
Last declaration on 11 February 2016
Declarations5 total
17,100 sharesCommon StockSEC:0001179110-16-018966:0
18,900 sharesCommon StockSEC:0001179110-16-018949:0
17,100 sharesCommon StockSEC:0001179110-16-018991:0
17,100 sharesCommon StockSEC:0001179110-16-018951:0
63,000 sharesCommon StockSEC:0001179110-16-018968:0
5 of 5 declarations
About Momenta Pharmaceuticals Inc
Momenta Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for autoimmune and rare diseases. It is listed on NASDAQ under the ticker MNTA.
